home / stock / cytk / cytk articles

CYTK Articles, Cytokinetics Incorporated - From 01/12/24

Stock Information
Company Name: Cytokinetics Incorporated
Stock Symbol: CYTK
Market: NASDAQ
Website: cytokinetics.com
Menu
CYTK CYTK Quote CYTK Short CYTK News CYTK Articles CYTK Message Board
Get CYTK Alerts

News, Short Squeeze, Breakout and More Instantly...
Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: Analyst | Benzinga

Thursday, Novartis AG (NYSE:NVS) decided to step back from pursuing the Cytokinetics Inc (NASDAQ:CYTK) acquisition, dealin...
Novartis Retreats From Cytokinetics Deal, Dashing Hopes For Multi-Billion Dollar Acquisition | Benzinga

Novartis AG (NYSE: NVS) has decided to step back from pursuing the Cytokinetics Inc (NASDAQ: CYTK) acquisition, dealing a blow ...

Aspen Aerogels Issues Business Update, Joins Plug Power, SunPower And Other Big Stocks Moving Lower On Thursday | Benzinga

U.S. stocks traded lower, with the Dow Jones index falling over 150 points on Thursday. Shares of Aspen Aerogels, Inc. (NYSE: ASPN) fell sharply du...

What's Been Happening With Cytokinetics Stock? | Benzinga

Cytokinetics, Incorporated (NASDAQ: CYTK) shares are trading lower on Tuesday, pulling back from Monday strength. What To Know: Cytokinetics stock ...
Why Is Heart Failure Drug-Focused Cytokinetic Stock Trading Higher Today? | Benzinga

Cytokinetics Inc (NASDAQ: CYTK) shares are trading higher after a report on potential takeover talks with Novartis AG (NYSE: NVS). T...

CACI International To Rally Around 21%? Here Are 10 Top Analyst Forecasts For Friday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Cytokinetics to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

SOUTH SAN FRANCISCO, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (NASDAQ:CYTK) today announced that Robert I. Blum, Pre...
Cytokinetics' Drug Potential: Analyst Suggests Key Role Of Established Pharma For Potential Launch | Benzinga

On Wednesday, Cytokinetics Incorporated (NASDAQ: CYTK) released topline results from the SEQUOIA-HCM Phase 3 trial of aficamten ...

Microsoft To Rally Over 20%? Here Are 10 Top Analyst Forecasts For Thursday | Benzinga

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...

Crude Oil Falls Over 1%; First Wave BioPharma Shares Spike Higher | Benzinga

U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.05% to...
Previous 10 Next 10